Rivaroxaban compared with enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients Alexander T Cohen On behalf of the MAGELLAN.
Kenneth W. Mahaffey, MD and Keith AA Fox, MB ChB on behalf of the ROCKET AF Investigators Rivaroxaban Once-daily oral direct factor Xa inhibition Compared.
Dr ranjith mp antithrombotics in af
Long term thérapy for PE of VTE
